Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/48355
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGauci, Marise-
dc.contributor.authorWirth, Francesca-
dc.contributor.authorAzzopardi, Lilian M.-
dc.contributor.authorSerracino-Inglott, Anthony-
dc.date.accessioned2019-11-06T09:16:59Z-
dc.date.available2019-11-06T09:16:59Z-
dc.date.issued2019-
dc.identifier.citationGauci, M., Wirth, F., Azzopardi, L. M., & Serracino-Inglott, A. (2019). Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons. Pharmacy Practice, 17(1), 1-7en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/48355-
dc.description.abstractBackground: Optimisation of drug therapy is important in the older population and may be facilitated by medication assessment tools (MATs). Objective: The purpose of the study was to evaluate whether appropriateness of drug therapy and clinical pharmacist intervention documentation improved following implementation of a previously developed MAT for the long-term management of atrial fibrillation (MAT-AF). Methods: Adherence to MAT-AF review criteria and clinical pharmacist intervention documentation was assessed by the researcher pre-MAT implementation in 150 patients aged ≥60 years admitted to a rehabilitation hospital with a diagnosis of atrial fibrillation. MAT-AF was introduced as a clinical tool in the hospital for identification of pharmaceutical care issues in atrial fibrillation patients. Adherence to MAT-AF and pharmacist intervention documentation were assessed by the researcher post-MAT implementation for a further 150 patients with the same inclusion criteria. Logistic regression analysis and measurement of odds ratio was used to identify differences in adherence to MAT-AF pre- and post-MAT implementation. The differences between two population proportions z-test was used to compare pharmacist intervention documentation pre- and post-MAT implementation. Results: Adherence to MAT-AF criteria increased from 70.9% pre-implementation to 89.6% post-implementation. MAT-AF implementation resulted in a significant improvement in prescription of anticoagulant therapy (OR 4.07, p<0.001) and monitoring of laboratory parameters for digoxin (OR 10.40, p<0.001). Clinical pharmacist intervention documentation improved significantly post-implementation of MAT-AF (z-score 20.249, p<0.001). Conclusions: Implementation of MAT-AF within an interdisciplinary health care team significantly improved the appropriateness of drug therapy and pharmacist intervention documentation in older patients with atrial fibrillation.en_GB
dc.language.isoenen_GB
dc.publisherRogers Publishing Ltd.,Les Editions Rogers Limiteeen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAtrial fibrillation -- Treatmenten_GB
dc.subjectDisease management -- Maltaen_GB
dc.subjectDrug utilization -- Maltaen_GB
dc.subjectTherapeutics -- Maltaen_GB
dc.subjectDrugs -- Prescribing -- Maltaen_GB
dc.subjectPharmaceutical services -- Maltaen_GB
dc.subjectPharmacists -- Maltaen_GB
dc.subjectMedical audit -- Maltaen_GB
dc.titleClinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older personsen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holderen_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.18549/PharmPract.2019.1.1349-
dc.publication.titlePharmacy Practiceen_GB
Appears in Collections:Scholarly Works - FacM&SPha



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.